Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Ottawa, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The global thrombectomy devices market size is expected to be worth over USD 3.29 billion by 2034, increasing from USD 1.76 billion in 2025, growing at a ...

The Food and Drug Administration (FDA) has granted 510 (k) clearance for Vesalio’s enVast clot retriever, paving the way for ...

A novel thrombectomy, or ‘stent on a wire,’ device continues to show positive results in acute stroke patients, achieving high rates of complete revascularization and good outcomes, especially in ...

A new class of stent retrieval device shows positive results in treating large, acute ischemic stroke, demonstrating favorable outcomes compared with thrombolytic therapy. The findings, from a small ...

Thrombectomy devices play a crucial role in the treatment of blood clot-related conditions, including ischemic stroke, deep vein thrombosis, and pulmonary embolism. The increasing incidence of ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the mechanical thrombectomy devices market and it is poised to grow by USD 246.15 million during 2020-2024, progressing at a CAGR of almost 7% ...

Mechanical Thrombectomy Devices Market Overview: The global mechanical thrombectomy devices market was valued at $760 million in 2021 and is expected to grow at a steady rate of 6% over the next five ...

The mechanical thrombectomy devices market is expected to grow at a steady rate during the forecast period. These devices are the gold standard for the treatment of blood clot and revascularization, ...